del Monte F, Kaumann A J, Poole-Wilson P A, Wynne D G, Pepper J, Harding S E
Department of Cardiac Medicine, National Heart and Lung Institute, London, England, UK.
Circulation. 1993 Sep;88(3):854-63. doi: 10.1161/01.cir.88.3.854.
Both beta 1- and beta 2-adrenoceptors (beta 1 AR and beta 2 AR) are present in human ventricle. This study was designed to determine whether the two subtypes contribute to contraction in single myocytes from human heart.
(-)-Epinephrine increased the contraction amplitude and velocity of single myocytes isolated from the ventricles of failing and nonfailing human hearts. Concentration-response curves to (-)-epinephrine were constructed in the presence and absence of selective antagonists for beta 1 AR (CGP 20712A) and beta 2 AR (ICI 118,551). Responses to (-)-epinephrine were antagonized to a variable degree by the blockers, suggesting heterogeneous contribution of beta 1AR and beta 2AR among cells. The most common response in single myocytes was that ICI 118,551 (50 nmol/L) shifted the concentration-response curve less than 10-fold: this was lower than the 100-fold shift expected for a pure beta 2AR effect. Inclusion of CGP 20712A (300 nmol/L) with ICI 118,551 shifted the (-)-epinephrine curve still further. These observations suggest that both beta 1AR and beta 2AR contribute to the increase in contraction amplitude with (-)-epinephrine in this group of myocytes. When 300 nmol/L CGP 20712A was present as the sole antagonist, only a marginal shift of the concentration-response curve for (-)-epinephrine was usually observed, indicating that beta 1AR were not mediating the effect of these low concentrations of (-)-epinephrine. Both beta 1AR and beta 2AR mediated a considerable abbreviation of the time to peak contraction and time to 50% relaxation in the single cells.
beta 1AR and beta 2AR coexist and function on human ventricular myocytes. At low (-)-epinephrine concentrations, contractile responses are predominantly mediated by beta 2AR rather than beta 1AR in myocytes from failing hearts.
β1 -和β2 -肾上腺素能受体(β1AR和β2AR)均存在于人类心室中。本研究旨在确定这两种亚型是否对人心脏单个心肌细胞的收缩有影响。
(-)-肾上腺素增加了从衰竭和非衰竭人类心室分离的单个心肌细胞的收缩幅度和速度。在存在和不存在β1AR(CGP 20712A)和β2AR(ICI 118,551)选择性拮抗剂的情况下,构建了对(-)-肾上腺素的浓度-反应曲线。阻滞剂对(-)-肾上腺素的反应有不同程度的拮抗作用,表明β1AR和β2AR在细胞间的作用存在异质性。单个心肌细胞中最常见的反应是ICI 118,551(50 nmol/L)使浓度-反应曲线的移动小于10倍:这低于纯β2AR效应预期的100倍移动。将CGP 20712A(300 nmol/L)与ICI 118,551一起使用会使(-)-肾上腺素曲线进一步移动。这些观察结果表明,在这组心肌细胞中,β1AR和β2AR均对(-)-肾上腺素引起的收缩幅度增加有作用。当300 nmol/L CGP 20712A作为唯一拮抗剂存在时,通常仅观察到(-)-肾上腺素浓度-反应曲线的微小移动,表明β1AR未介导这些低浓度(-)-肾上腺素的作用。β1AR和β2AR均介导了单个细胞中收缩峰值时间和50%舒张时间的显著缩短。
β1AR和β2AR共存于人类心室肌细胞并发挥作用。在低浓度(-)-肾上腺素时,衰竭心脏的心肌细胞收缩反应主要由β2AR而非β1AR介导。